Roivant Sciences Ltd WT (ROIVW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIVW | ATNF | BDRX | ||
| Company | Roivant Sciences Ltd WT | 180 Life Sciences Corp | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.86 | 1.9800 | 4.00 | ||
| High | 2.92 | 2.0200 | 4.22 | ||
| Low | 2.75 | 1.8600 | 3.90 | ||
| Last | 2.75 | 1.8600 | 3.99 | ||
| Change | -0.11 | -0.0800 | -0.01 | ||
| % Change | -3.85% | -4.12% | -0.25% | ||
| Volume | 37,800 | 54,500 | 24,300 | ||
| 20-Day Average Volume | 201,870 | 129,780 | 91,885 | ||
| Previous Close | 2.86 | 1.9400 | 4.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 2.0855 | 4.78 | ||
| 20-Day Raw Stochastic | 39.13% | 15.67% | 5.28% | ||
| 20-Day Relative Strength | 49.75% | 41.44% | 38.93% | ||
| Weighted Alpha | +210.22 | -87.86 | -92.84 | ||
| Today's Opinion | 48% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 96% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 16% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 08/25/23 | -3.63% since 12/13/24 | -5.00% since 12/13/24 | ||
| Low | 2.75 on 09/01/23 | 1.6900 on 12/17/24 | 3.80 on 12/19/24 | ||
| High | 2.93 on 08/31/23 | 2.0200 on 12/20/24 | 4.39 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -15.12% since 08/01/23 | -20.51% since 11/20/24 | +3.64% since 11/20/24 | ||
| Low | 2.57 on 08/17/23 | 1.6900 on 12/17/24 | 3.80 on 12/19/24 | ||
| High | 3.21 on 08/02/23 | 2.7750 on 12/02/24 | 7.47 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | +30.95% since 06/01/23 | -5.58% since 09/20/24 | -45.36% since 09/20/24 | ||
| Low | 1.92 on 06/27/23 | 1.1600 on 10/08/24 | 3.50 on 11/19/24 | ||
| High | 4.00 on 07/06/23 | 17.7500 on 10/16/24 | 10.89 on 10/16/24 | ||
| 6-Month | |||||
| %Chg | +59.88% since 03/01/23 | +14.11% since 06/20/24 | -83.88% since 06/20/24 | ||
| Low | 1.23 on 03/23/23 | 1.1600 on 10/08/24 | 3.50 on 11/19/24 | ||
| High | 4.00 on 07/06/23 | 17.7500 on 10/16/24 | 41.50 on 07/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 1,910 | 475 | ||
| Shares Outstanding, K | N/A | 1,027 | 119 | ||
| Annual Sales | 124,800,000 | 0 | 410,000 | ||
| Annual Net Income | 4,348,930,000 | -19,940,000 | -7,660,000 | ||
| Last Quarter Sales | 4,475,000 | 0 | N/A | ||
| Last Quarter Net Income | -230,184,000 | -840,000 | N/A | ||
| 60-Month Beta | N/A | 0.12 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.85 on 11/14/24 | N/A | ||
| Latest Earnings Date | 02/11/25 | 11/14/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||